Global health starts with trusted medicines

Featured products

Catheter Prep Solution Family-3616 1

Chlorhexidine Topical

LumaCina’s Chlorhexidine Topical Solution is an antiseptic formulated for hospital use, supplied in a convenient 30 mL blow-fill-seal (BFS) unit. Each dose is prepared with sterile water and sealed with an easy-tear cap—designed for safe, efficient use in clinical settings where sterility and speed matter most.

Read More arrow-right
Sodium Chloride 90mg 50x10 Product-3493

Sodium Chloride Injection

LumaCina’s 0.9% Sodium Chloride Injection is supplied in sterile blow-fill-seal (BFS) ampoules of 5 mL, 10 mL, 20 mL, and 30 mL. Formulated for hospital use, it serves as a versatile diluent or flush solution, with convenient single-use formats that support aseptic technique and reduce contamination risk.

Read More arrow-right
grow-with-lumacina

Grow with LumaCina

Bring Your Products to Australia & New Zealand

Tap into a proven platform for hospital medicines in Australia and New Zealand. LumaCina partners with companies to deliver sterile injectables and specialty products where they’re needed most — with the local knowledge and trusted networks to make it happen.
Contact Us

Contact Us arrow-right

Distribute LumaCina’s Products in Your Market

LumaCina’s core portfolio consists of legacy Pfizer medicines, manufactured in Australia to the highest quality standards. Trusted by hospitals across the region, these products continue to play a vital role in patient care. We’re seeking experienced partners to expand access in markets where they’re needed most.
Contact Us

Contact Us arrow-right
trusted-medicines

Trusted Medicines. Proven Platform.

Product & Market Expertise

Our team brings deep experience across hospital procurement, product registration, and commercialization of sterile injectables and specialty medicines. We know how to navigate complex markets — and how to move quickly when patients are waiting.

Morearrow-right

Established Supply Network

LumaCina connects global manufacturers with healthcare providers across the world. Our platform ensures continuity of supply, compliance with local standards, and access to hospital channels.

Morearrow-right

Institutional Backing

Bridgewest Group is a $3B privately held investment group, which has been building, scaling, and operating businesses in the life sciences industry for over 20 years.

Morearrow-right

About us

LumaCina supplies essential medicines to hospital systems across Australia, New Zealand, and select global markets. The portfolio continues to expand through strategic partnerships and targeted development, with a commitment to broadening access to trusted treatments worldwide.

Our Companyarrow-right
map
company
78+

Over 78 trusted, high-quality injectable medicines delivered to countries worldwide.